BAHD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.22044604925031E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.69000394076602E-11 |
Normal-vs-Stage2 |
1.98630001335687E-09 |
Normal-vs-Stage3 |
1.62436730732907E-12 |
Normal-vs-Stage4 |
1.62436730732907E-12 |
Stage1-vs-Stage2 |
1.541990E-01 |
Stage1-vs-Stage3 |
2.2831000423551E-09 |
Stage1-vs-Stage4 |
7.17409999961838E-07 |
Stage2-vs-Stage3 |
2.122200E-02 |
Stage2-vs-Stage4 |
1.785580E-02 |
Stage3-vs-Stage4 |
6.801400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62470037423645E-12 |
Normal-vs-AfricanAmerican |
8.405800E-04 |
Normal-vs-Asian |
1.005540E-02 |
Caucasian-vs-AfricanAmerican |
7.823700E-04 |
Caucasian-vs-Asian |
4.499400E-01 |
AfricanAmerican-vs-Asian |
4.748600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
2.89489543447985E-11 |
Male-vs-Female |
5.233100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.92880000146911E-08 |
Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(61-80Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(81-100Yrs) |
2.09460000011319E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.070600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.756800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.941800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.920800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.402000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.043200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.124000E-01 |
Normal-vs-Grade 2 |
1.41964218158819E-12 |
Normal-vs-Grade 3 |
1.6242562850266E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.564400E-04 |
Grade 1-vs-Grade 3 |
1.12399999974144E-07 |
Grade 1-vs-Grade 4 |
2.58239984951558E-10 |
Grade 2-vs-Grade 3 |
1.248340E-04 |
Grade 2-vs-Grade 4 |
5.99530003420057E-09 |
Grade 3-vs-Grade 4 |
1.581430E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.80588918555713E-12 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
8.204900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62436730732907E-12 |
Normal-vs-N1 |
7.34989846762346E-11 |
N0-vs-N1 |
4.162800E-03 |
|
|